Age-related changes in pre- and postmenopausal women investigated with 18F-fluoride PET - A preliminary study

Skeletal Radiology

Volumn 41, Issue 8, 2012, Pages 947-953

  Kurata, Seiji ^a   Shizukuishi, Kazuya ^b   Tateishi, Ukihide ^b   Yoneyama, Tomohiro ^b   Hino, Ayako ^b   Ishibashi, Masatoshi ^a   Inoue, Tomio ^b  

^a KURUME UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

18F fluoride; Advancing age; Bone metabolism; Menopause; PET

Indexed keywords

FLUORINE 18;

ADULT; AGE; AGED; AGING; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HUMAN; HUMERUS; LUMBAR SPINE; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TRABECULAR BONE;

ADULT; AGED; AGING; BONE RESORPTION; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; RADIOPHARMACEUTICALS;

EID: 84863985445     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-011-1318-9     Document Type: Article

References (34)

1. WHO. Technical report series 843. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: World Health Organization; 1994.
2. Custer RP. An atlas of the blood and bone marrow. Philadelphia: Saunders; 1949.
3. Rico H. The therapy of osteoporosis and the importance of cortical bone. Calcif Tissue Int. 1997;61:431-2.
4. Recker RR. Bone biopsy and histomorphometry in clinical practice. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Washington, D. C.: American Society for Bone and Mineral Research; 2008. p. 180-6.
5. Szulc P, Delmas PD. Biochemical markers of turnover in osteoporosis. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Washington, D. C.: American Society for Bone and Mineral Research; 2008. p. 174-9.
6. Looker AC, Bauer DC, Chesnut 3rd CH, et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int. 2000;11:467-80.
7. Blake GM, Fogelman I. Technical principles of dual energy X-ray absorptiometry. Semin Nucl Med. 1997;27:210-28. (Pubitemid 27291420)
8. Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005;90:6508-15. (Pubitemid 41759306)
9. Blau M, Ganatra R, Bender MA. 18F-fluoride for bone imaging. Semin Nucl Med. 1972;2:31-7.
10. Narita N, Kato K, Nakagaki H, Ohno N, Kameyama Y, Weatherell JA. Distribution of fluoride concentration in rat bone. Calcif Tissue Int. 1990;46:200-4. (Pubitemid 20084077)
11. Uchida K, Nakajima H, Miyazaki T, et al. Effects of alenderonate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study. J Nucl Med. 2009;50:1808-14.
12. Cook GJ, Lodge MA, Blake GM, Marsden PK, Fogelman I. Differences in skeletal kinetics between vertebral and humeral bone measured by 18F-fluoride positron emission tomography in postmenopausal women. J Bone Miner Res. 2000;15:763-9. (Pubitemid 30174030)
13. Frost ML, Blake GM, Park-Holohan SJ, et al. Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. J Nucl Med. 2008;49:700-7. (Pubitemid 351717533)
14. Blake GM, Siddique M, Frost ML, Moore AE, Fogelman I. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover? Bone. 2011;49:537-42.
15. Subramanin G. Radiopharmaceuticals for bone scanning. In: Collier BD, Fogelman I, Rosenthall L, editors. Skeletal nuclear medicine. St. Louis: Mosby; 1996. p. 9-29.
16. Piert M, Zittel TT, Becker GA, et al. Assessment of porcine bone metabolism by dynamic 18F-fluoride ion PET: correlation with bone histomorphometry. J Nucl Med. 2001;42:1091-100. (Pubitemid 32595310)
17. Ishiguro K, Nakagaki H, Tsuboi S, et al. Distribution of fluoride in cortical bone of human rib. Calcif Tissue Int. 1993;52:278-82. (Pubitemid 23097159)
18. Brenner W, Vernon C, Muzi M, et al. Comparison of different quantitative approaches to 18F-fluoride PET scans. J Nucl Med. 2004;45:1493-500. (Pubitemid 47618503)
19. Riggs BL, Melton 3rd LJ. Involutional osteoporosis. N Engl J Med. 1986;314:167-8.
20. Politics C, Karamerou A, Block M. Pathophysiologic aspects of the bone/marrow/fat relationship. Lab Manage. 1983;21:40-55.
21. Krempien B, Lemminger FM, Ritz E, Weber E. The reaction of different skeletal sites to metabolic bone disease-a micromorphometric study. Klin Wochenschr. 1978;56:755-9. (Pubitemid 8394259)
22. Hawkins RA, Choi Y, Huang SC, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med. 1992;233:633-42.
23. Reeve J, Arlot M, Wootton R, et al. Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: a relationship between blood flow and corrected apposition rate. J Clin Endocrinol Metab. 1988;66:1124-31.
24. Prisby RD, Ramsey MW, Behnke BJ, et al. Aging reduces skeletal blood flow, endothelium-dependent vasodilation, and NO bioavailablity in rats. J Bone Miner Res. 2007;22:1280-8. (Pubitemid 351339710)
25. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med. 1997;38:1970-6. (Pubitemid 28030932)
26. Van Dyke D. Similarity in distribution of skeletal blood flow and erythropoietic marrow. Clin Orthop Relat Res. 1967;52:37-51.
27. Gross PM, Heistad DD, Marcus ML. Neurohumoral regulation of blood flow to bones and marrow. Am J Physiol. 1979;237:440-8.
28. Reid IR. Menopause. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Washington, D. C.: American Society for Bone and Mineral Research; 2008. p. 95-7.
29. Kricum ME. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol. 1985;14:10-9.
30. Hashimoto M. Pathology of bone marrow. Acta Haematol. 1962;27:193-216.
31. Blake GM, Park-Holohan SJ, Cook GJ, Fogelman I. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med. 2001;31:28-49. (Pubitemid 32060651)
32. Piert M, Zittel TT, Machulla HJ, et al. Blood flow measurements with [(15) O]H2O and [18F]fluoride ion PET in porcine vertebrae. J Bone Miner Res. 1998;13:1328-36. (Pubitemid 28373335)
33. Morris MA, Kelly PJ. Use of tracer microspheres to measure bone blood flow in conscious dogs. Calcif Tissue Int. 1980;32:69-76. (Pubitemid 11224102)
34. Rahme R, Moussa R. The modic vertebral endplate and marrow changes: pathologic significance and relation to low back pain and segmental instability of the lumbar spine. AJNR Am J Neuroradiol. 2008;29:838-42. (Pubitemid 351684952)